SUPN · Supernus Pharmaceuticals, Inc. · Executive Compensation
$41.20
-0.03 (-0.07%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$2.40B
Shares
58.13M
Volume · Oct 21
1.01M
Avg daily vol (3M)
816.71K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Jack Khattar | CEO | $15,501,557 |
| Jack A. Khattar | Chief Executive Officer, President & Secretary | $15,501,557 |
| Timothy C. Dec | Senior Vice President, Chief Financial Officer | $1,916,409 |
| Jonathan Rubin | Senior Vice President, Chief Medical Officer Research and Development | $1,448,731 |
| Padmanabh P. Bhatt | Senior Vice President, Intellectual Property, Chief Scientific Officer | $1,391,429 |
| Frank Mottola | Senior Vice President, Chief Technical Operations Officer | $1,360,701 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Jack Khattar | CEO | $17,848,004 |
| Jack A. Khattar | Chief Executive Officer, President & Secretary | $17,848,004 |
| Timothy C. Dec | Senior Vice President, Chief Financial Officer | $2,953,048 |
| Jonathan Rubin | Senior Vice President, Chief Medical Officer Research and Development | $1,825,608 |
| Frank Mottola | Senior Vice President, Quality GMP Operations, Information Technology and Regulatory Affairs | $1,686,949 |
| Padmanabh P. Bhatt | Senior Vice President, Intellectual Property, Chief Scientific Officer | $1,552,229 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Jack Khattar | CEO | $13,278,093 |
| Jack A. Khattar | Chief Executive Officer, President & Secretary | $13,278,093 |
| Timothy C. Dec | Senior Vice President, Chief Financial Officer | $2,383,597 |
| Frank Mottola | Senior Vice President, Quality GMP Operations, Information Technology and Regulatory Affairs | $1,786,179 |
| Jonathan Rubin | Senior Vice President, Chief Medical Officer Research and Development | $1,587,329 |
| Padmanabh P. Bhatt | Senior Vice President, Intellectual Property, Chief Scientific Officer | $1,468,211 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Jack A. Khattar | Chief Executive Officer, President & Secretary | $10,012,717 |
| Jack Khattar | CEO | $10,012,717 |
| Timothy C. Dec | Senior Vice President, Chief Financial Officer | $1,263,370 |
| Jonathan Rubin | Senior Vice President, Chief Medical Officer Research and Development | $1,254,788 |
| Padmanabh P. Bhatt | Senior Vice President, Intellectual Property, Chief Scientific Officer | $1,120,759 |
| Frank Mottola | Senior Vice President, Quality GMP Operations, Information Technology and Regulatory Affairs | $1,029,939 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Jack Khattar | CEO | $8,116,721 |
| Jack A. Khattar | Chief Executive Officer, President & Secretary | $8,116,721 |
| Jonathan Rubin | MD Senior Vice President, Chief Medical Officer Research and Development | $1,028,349 |
| Padmanabh P. Bhatt | Senior Vice President, Intellectual Property, Chief Scientific Officer | $933,265 |
| Tami T. Martin | R.N., Esq. Senior Vice President, Regulatory Affairs | $843,157 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Jack Khattar | CEO | $6,669,046 |
| Jack A. Khattar | Chief Executive Officer, President & Secretary | $6,669,046 |
| James P. Kelly | Executive Vice President, Chief Financial Officer | $1,801,636 |
| Stefan K.F. Schwabe | M.D., Ph.D. Executive Vice President of Research and Development, Chief Medical Officer | $1,189,554 |
| Gregory S. Patrick | Senior Vice President, Chief Financial Officer | $1,152,802 |
| Padmanabh P. Bhatt | Senior Vice President, Intellectual Property, Chief Scientific Officer | $1,074,490 |
| Tami T. Martin | R.N., Esq. Senior Vice President, Regulatory Affairs | $804,637 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Jack A. Khattar | Chief Executive Officer, President & Secretary | $8,123,132 |
| Jack Khattar | CEO | $8,123,132 |
| Stefan K.F. Schwabe | M.D., Ph.D. Executive Vice President of Research and Development, Chief Medical Officer | $1,469,056 |
| Gregory S. Patrick | Senior Vice President, Chief Financial Officer | $1,440,587 |
| Padmanabh P. Bhatt | Senior Vice President, Intellectual Property, Chief Scientific Officer | $1,311,587 |
| Tami T. Martin | R.N., Esq. Senior Vice President, Regulatory Affairs | $874,819 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Jack A. Khattar | Chief Executive Officer, President & Secretary | $7,220,419 |
| Jack Khattar | CEO | $7,220,419 |
| Stefan K.F. Schwabe | M.D., Ph.D. Executive Vice President of Research and Development, Chief Medical Officer | $1,279,199 |
| Gregory S. Patrick | Senior Vice President, Chief Financial Officer | $1,235,621 |
| Padmanabh P. Bhatt | Senior Vice President, Intellectual Property, Chief Scientific Officer | $1,229,803 |
| Tami T. Martin | R.N., Esq. Senior Vice President, Regulatory Affairs | $725,039 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Jack A. Khattar | Chief Executive Officer, President & Secretary | $5,571,674 |
| Jack Khattar | CEO | $5,571,674 |
| Stefan K.F. Schwabe | M.D., Ph.D. Executive Vice President of Research and Development, Chief Medical Officer | $1,248,382 |
| Gregory S. Patrick | Senior Vice President, Chief Financial Officer | $1,195,094 |
| Padmanabh P. Bhatt | Senior Vice President, Intellectual Property, Chief Scientific Officer | $1,063,281 |
| Tami T. Martin | R.N., Esq. Senior Vice President, Regulatory Affairs | $670,957 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Tony Kingsley | Board Chair of the combined company | Appointed | 2026-08-03 |
| Jack Khattar | President, Chief Executive Officer and a member of the Board of Directors of the combined company | Appointed | 2026-08-03 |
| Jack A. Khattar | member of the Combined Company Board | Appointed | 2026-08-03 |
| Timonthy C. Dec | Chief Financial Officer | Appointed | 2026-08-03 |
| Jack A. Khattar | Chief Executive Officer | Appointed | 2026-08-03 |
| Frank Mottola | Chief Technical Operations Officer | Appointed | 2025-08-04 |
| John M. Siebert, Ph.D. | Board of Directors | Retired | 2024-04-24 |
| Roman Bradel, Ph.D. | Vice President, Regulatory Affairs | Appointed | 2024-02-21 |
| Tami T. Martin, R.N., Esq. | Senior Vice President, Regulatory Affairs | Retired | 2024-02-21 |
| Bethany L. Sensenig | member of the Board of Directors | Appointed | 2023-08-21 |
Leadership
- Jack A. Khattar CEO, Board Member
- Jack Khattar CEO, Board Member
- Tony Kingsley Chairman
- James Kelly CFO
- James P. Kelly CFO
- Timonthy C. Dec CFO
- Timothy C. Dec CFO
- Bethany L. Sensenig Board Member
- Carrolee Barlow Board Member
- Charles W. Newhall Board Member
- Frederick M. Hudson Board Member
- Georges Gemayel Board Member
Key facts
CIK
1356576
CUSIP
868459108
13F (30d)
37 filings
36 filers
Visit website
Investor relations